![](/img/cover-not-exists.png)
A phase II trial to evaluate the efficacy of fostamatinib in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL)
Flinn, Ian W., Bartlett, Nancy L., Blum, Kristie A., Ardeshna, Kirit M., LaCasce, Ann S., Flowers, Christopher R., Shustov, Andrei R., Thress, Kenneth S., Mitchell, Patrick, Zheng, Fred, Skolnik, JeffVolume:
54
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2015.10.005
Date:
February, 2016
File:
PDF, 293 KB
english, 2016